Recent Advances in the Heterologous Biosynthesis of Natural Products from Streptomyces

• Published in: Applied sciences 2021-02, Vol.11 (4), p.1851
• Main Authors: Pham, Van Thuy Thi, Nguyen, Chung Thanh, Dhakal, Dipesh, Nguyen, Hue Thi, Kim, Tae-Su, Sohng, Jae Kyung
• Format: Article
• Language: English
• Subjects: Antibiotics; Bioinformatics; Biosynthesis; Cloning; Deoxyribonucleic acid; DNA; Drugs; Gene clusters; Gene deletion; Genetic control; Genetic engineering; Genomes; Gram-positive bacteria; heterologous expression; Host selection; Mass spectrometry; Metabolism; Metabolites; Natural products; Peptides; Pesticides; Rodeos; Scientific imaging; secondary metabolite; Secondary metabolites; Streptomyces
• ISSN: 2076-3417; 2076-3417
• DOI: 10.3390/app11041851

Streptomyces is a significant source of natural products that are used as therapeutic antibiotics, anticancer and antitumor agents, pesticides, and dyes. Recently, with the advances in metabolite analysis, many new secondary metabolites have been characterized. Moreover, genome mining approaches demonstrate that many silent and cryptic biosynthetic gene clusters (BGCs) and many secondary metabolites are produced in very low amounts under laboratory conditions. One strain many compounds (OSMAC), overexpression/deletion of regulatory genes, ribosome engineering, and promoter replacement have been utilized to activate or enhance the production titer of target compounds. Hence, the heterologous expression of BGCs by transferring to a suitable production platform has been successfully employed for the detection, characterization, and yield quantity production of many secondary metabolites. In this review, we introduce the systematic approach for the heterologous production of secondary metabolites from Streptomyces in Streptomyces and other hosts, the genome analysis tools, the host selection, and the development of genetic control elements for heterologous expression and the production of secondary metabolites.